# STAY-STRONG Study of Exercise Training During Chemotherapy

> **NCT05556239** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 42 (actual)

## Conditions studied

- Lymphoma, B-Cell
- Lymphoma, Hodgkin
- Exercise
- Body Composition
- Physical Functional Performance
- Quality of Life
- Sarcopenia
- Muscle, Skeletal
- Patient Reported Outcome Measures

## Interventions

- **BEHAVIORAL:** Resistance Exercise Training

## Key facts

- **NCT ID:** NCT05556239
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-25
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05556239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05556239, "STAY-STRONG Study of Exercise Training During Chemotherapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05556239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*